Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotropin for repair of acute spinal cord injury
ChiCTR2000031922Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jun 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of vaccinia virus-inoculated rabbit skin extract in spinal cord injury (SCI) (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: ASIA spinal cord injury score, Neuroelectrophysiological examination and 1 more. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
vaccinia virus-inoculated rabbit skin extract
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on ChiCTR2000031922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031922.